[DE] INDOL-PHENYLSULFONAMID-DERIVATE ALS PPAR-DELTA AKTIVIERENDE VERBINDUNGEN [EN] INDOLE-PHENYLSULFONAMIDE DERIVATIVES USED AS PPAR-DELTA ACTIVATING COMPOUNDS [FR] DERIVES D'INDOL-PHENYLSULFONAMIDE UTILISES COMME COMPOSES ACTIVANT LE RECEPTEUR PPAR-DELTA
INDOL-PHENYLSULFONAMID-DERIVATE ALS PPAR-DELTA AKTIVIERENDE VERBINDUNGEN
申请人:Bayer HealthCare AG
公开号:EP1583743A1
公开(公告)日:2005-10-12
[DE] INDOL-PHENYLSULFONAMID-DERIVATE ALS PPAR-DELTA AKTIVIERENDE VERBINDUNGEN<br/>[EN] INDOLE-PHENYLSULFONAMIDE DERIVATIVES USED AS PPAR-DELTA ACTIVATING COMPOUNDS<br/>[FR] DERIVES D'INDOL-PHENYLSULFONAMIDE UTILISES COMME COMPOSES ACTIVANT LE RECEPTEUR PPAR-DELTA
申请人:BAYER HEALTHCARE AG
公开号:WO2004060871A1
公开(公告)日:2004-07-22
Die vorliegende Anmeldung betrifft neue Indol-Phenylsulfonamid-Derivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln, insbesondere als potente PPAR-delta aktivierende Verbindungen zur Prophylaxe und/oder Behandlung kardiovaskulärer Erkrankungen, insbesondere von Dyslipidämien und koronaren Herzkrankheiten.
Indole-phenylsulfonamide derivatives used as ppar-delta activating compounds
申请人:Woltering Michael
公开号:US20070149514A1
公开(公告)日:2007-06-28
The invention relates to novel indole-phenylfulfonamide derivatives, to methods for the production thereof, and to their use in medicaments, particularly as potent PPAR-delta activating compounds, for the prevention and/or treatment of cardiovascular diseases, particularly dyslipidemias and coronary heart diseases.